Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/2/2010

, but by way of example, statements contained in this press release relating to ISTA's 2010 and 2011 expected financial results, the successful launch of once-daily BROMDAY, filing of the IND and initiation of a Phase 2 bepotastine nasal spray study before the end of 2010, completion of the REMURA Phase 3 efficacy and safety studies and reporting of efficacy results in the middle of 2011, the successful growth of BEPREVE, the continued growth of ISTA's XIBROM/BROMDAY franchise, timing and outcome of the royalty litigation between ISTA and Senju and ISTA's prospects for its long-term financial growth are forward-looking statements.  Except as required by law, ISTA disclaims any intent or obligation to update any forward-looking statements.  These forward-looking statements are based on ISTA's expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, among other things, risks associated with: timely receipt and maintenance of regulatory approvals for ISTA's products and product candidates, and continued compliance with the FDA and/or other governmental regulations applicable to ISTA's facilities, products and/or business; successful and timely completion of clinical trials and other research and development efforts for ISTA's product candidates; successful implementation of any product acquisition or in-licensing transactions that ISTA might pursue and close; generic manufacturers' receipt of approval for generic versions of ISTA's products; market acceptance of and demand for ISTA's approved products and the impact of competitive products and pricing; ISTA's ability to manage its anticipated growth; ISTA's ability to raise capital on favorable terms in the future, if required; unpredictable and unstable changes in economic conditions; continued compliance with third-party borrowing arrangements; timely performance by ISTA's strateg
'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
2. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
3. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
6. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
7. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
10. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
11. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Texas , March 2, 2015 /PRNewswire/ ... of the population with nearly 38,000 of ... (Methicillin-resistant Staphylococcus Aureus), a highly contagious disease, ... 19,000 deaths.  Each of these and more, ... transmitted through casual contact with other infectious ...
(Date:3/2/2015)... Calif. , March 2, 2015  CytomX, ... treatment of cancer, today announced the creation of ... researchers and clinicians in the fields of cancer ... The new advisory boards will provide guidance to ... pipeline of precision immunotherapies and Probody drug conjugates. ...
(Date:3/2/2015)... DIEGO , March 2, 2015   ... clinical-stage biopharmaceutical company, today announced preliminary findings from ... in a model of chronic, stable heart failure ... this study was to examine the effects of ... (LV) systolic and diastolic function. ...
Breaking Medicine Technology:Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 2Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 3CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 2Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 4Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 5Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 6
... BEACH, Fla., Jan. 26, 2012 China Nuvo Solar ... name change to SurgLine International, Inc. has been completed ... under the new OTC ticker symbol: SGLN, effective tomorrow, ... owned operating subsidiary of SGLN. Thomas Toland, ...
... diversion and the health consequences of prescription drug misuse ... physicians," states American Society of Addiction Medicine (ASAM) Acting ... are overdosing on prescription pain medication and many of ... Chronic pain and addiction are issues faced by ...
Cached Medicine Technology:China Nuvo Solar Energy, Inc. Completes Name Change to SurgLine International, Inc. 2ASAM Approves Prescription Drug Policy 2
(Date:3/2/2015)... “ Wants and Needs ” was featured ... features the latest and coolest mobile applications on the ... technology expert and host of NewsWatch, conducted the app ... people evaluate priorities. , Whether a person needs help ... app. The app allows people to enter and track ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Gummy smile ... reshaping procedures. Gum reshaping can involve one or several procedures ... regenerate lost gum tissue for a more even gum line. ... gum line treatment that can permanently lighten discolored or ... smile approach, which involves a personalized treatment plan to address ...
(Date:3/2/2015)... 02, 2015 The Workgroup for Electronic ... the use of health IT to create efficiencies in ... Testing for Small Providers.” The white paper by WEDI’s ... point for ICD-10 testing by focusing on primary considerations ... compliance with the October 1, 2015 implementation date. Download ...
(Date:3/2/2015)... PORTLAND, Oregon (PRWEB) March 02, 2015 ... world’s largest online healthcare certification programs, including ... compliance, and dietary supplement safety and classification, ... sellers of prescription eyeglasses. The new program, ... eyeglasses prescription verification, transparency regarding the identity ...
(Date:3/2/2015)... A true renaissance man—some might call him ... cult rock band Khazad Doom, has long inspired his countless ... despite all odds. His motto throughout his life has always ... goal was before him. And that attitude, born amidst the ... on to a new generation. , As Eadon knows, when ...
Breaking Medicine News(10 mins):Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3
... whether to preserve the Roman Catholic Church's "traditional ban ... that gives us an effective weapon against AIDS -- ... infallibility to new challenges," according to Peter Boulay, former ... ,Cardinal Javier Lozano Barragan in April said that ...
... Hong Kong health director Margaret Chan Tuesday emerged as ... Health Organisation (WHO). // ,The 60-year-old obstetrician, who ... a five-person shortlist of candidates released overnight ahead of ... ,Chan got 32 votes in the first round of ...
... in delayed healing in mice. It is quite shocking ... having harmful effects on variety of orthopedic conditions are ... that the toxins contained in cigarette can undermine fracture ... are highly prone to hip fractures, healing problems, bone ...
... or emotional instability during childhood or at any period ... severe health disorder, according to recent studies. // ... to become so lethargic that he or she can't ... It affects between 400,000 and 900,000 American adults. , ...
... practice of using duct tape a strong wide adhesive tape ... on skin of hands or feet in schoolchildren. ... popularly attested belief that duct tape is helpful in some ... to popular belief the duct tape only works slightly better ...
... percent rise in the number of tuberculosis cases in ... latest official figures reveal. ,The largest increase ... from 4,696 in 2004 to 5,310 in 2005, figures ... head of the Respiratory Diseases Department at the Agency, ...
Cached Medicine News:Health News:Consequences Of Smoking On Fractures & Ligament Injuries 2Health News:TB Cases On The Rise Among British Asians 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: